Ozempic
Patients who used Ozempic, Mounjaro, or other diabetes and weight loss drugs and have been diagnosed with gastroparesis, stomach paralysis (“frozen stomach”), or other serious gastrointestinal conditions may qualify to file a lawsuit and receive compensation for their injuries.
Ozempic (semaglutide) was originally developed and approved by the FDA as a treatment for type 2 diabetes. After the drug was released in 2017, doctors realized that Ozempic could also be effective at treating patients with obesity.
Ozempic became so widely prescribed for weight management that the FDA officially added these medications to its drug shortages list in 2023. However, around this time, media outlets also began reporting on serious stomach problems among patients who were taking these drugs for weight loss or diabetes treatment.
Some patients who have used Ozempic or similar semaglutides have developed gastroparesis, a chronic condition which causes a weakening of the nerves and muscles in the stomach. Because these nerves and muscles are weaker in patients with gastroparesis, patients with this condition have trouble transferring food to the small intestines, causing nausea, diarrhea, or other side effects.
In addition to Ozempic, the FDA has also received reports of serious stomach conditions linked to other drugs used for weight loss and diabetes treatment.
These medications – along with Ozempic – are part of a class of medications known as GLP-1 receptor agonists.
Other brand name and generic medications that are part of this class of drugs include:
- Mounjaro (tirzepatide)
- Rybelsus (semiglutide)
- Saxenda (liraglutide)
- Trulicity (dulaglutide)
Besides gastroparesis, Ozempic, and the above medications have also been linked to other serious stomach conditions, including:
- Bowel obstructions
- Ileus (inability of the intestine to push food or waste out of the body)
- Intestinal blockages
- Stomach paralysis (“frozen stomach”)
Did you or a loved one used Ozempic, or a similar semiglutide, that have been linked to gastroparesis or other serious stomach conditions?
If so, you may be eligible to file a lawsuit and receive compensation from the manufacturers of these drugs. Contact Brent Coon & Associates now for a free consultation.
search
our offices
FROM THE BLOG
TEXAS LAWYER – Judge Spends 3 Hours Explaining His Decision
TEXAS LAWYER – January 17, 2025 – By Adolfo Pesquera A judge sympathetic to the hundreds of victims of the massive Port Neches refinery explosion was not able to convince the defendant corporation to pay $292 A proposed plea agreement between federal prosecutors and TPC Group that involved negotiations that excluded the crime victims, fell…
FEDERAL JUDGE LOWERS THE BOOM ON TPC FOR CRIMINAL CHARGES BROUGHT BY THE DEPARTMENT OF JUSTICE / TPC WALKS
FEDERAL JUDGE LOWERS THE BOOM ON TPC FOR CRIMINAL CHARGES BROUGHT BY THE DEPARTMENT OF JUSTICE / TPC WALKS On Friday, January 10, 2025, Federal Court Judge Michael Truncale called the attorneys representing the victims of the TPC refinery explosion case, TPC defense counsel and the Government prosecutors back to his courtroom so he could…
UPDATE ON TPC LITIGATION – TPC Withdraws from Plea Agreement
Beaumont — TPC has withdrawn from its plea agreement with the government during a federal sentencing hearing for the 2019 plant explosion and fire in Port Neches, based on the judge’s decision to increase restitution, and TPC is now prepared to go to trial. U.S. District Court Judge Michael Truncale held the hearing Friday at…